Diagnostic significance of overexpression of Golgi membrane protein 1 in prostate cancer (Q39307184)

10 September 2017

title

Diagnostic significance of overexpression of Golgi membrane protein 1 in prostate cancer (English)

1 reference

10 September 2017

1 reference

1 reference

1 reference

Wenzhi Li

1 reference

10 September 2017

Xiang Wang

1 reference

10 September 2017

Bin Li

1 reference

10 September 2017

Jiancheng Lu

1 reference

10 September 2017

Gang Chen

1 reference

10 September 2017

language of work or name

English

0 references

publication date

25 July 2012

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

952.e1-7

1 reference

10 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Changing demography of prostate cancer in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Prostate-specific antigen in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Paclitaxel induces apoptosis through activation of nuclear protein kinase C-δ and subsequent activation of Golgi associated Cdk1 in human hormone refractory prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

GP73, a novel Golgi-localized protein upregulated by viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Disease- and cell-specific expression of GP73 in human liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Hepatocyte GP73 expression in Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Gene expression analysis of prostate cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Capacity of the Golgi apparatus for cargo transport prior to complete assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Insertional mutation in the Golgb1 gene is associated with osteochondrodysplasia and systemic edema in the OCD rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

[Diagnosis of tumours of the liver and the biliary tract: new tissue and serum markers]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.06.017

10.1016/J.UROLOGY.2012.06.017

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference